Global Pertuzumab Biosimilars Supply, Demand and Key Producers, 2023-2029
The global Pertuzumab Biosimilars market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Pertuzumab is a recombinant humanized monoclonal antibody targeting HER2
This report studies the global Pertuzumab Biosimilars production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pertuzumab Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pertuzumab Biosimilars that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pertuzumab Biosimilars total production and demand, 2018-2029, (K Units)
Global Pertuzumab Biosimilars total production value, 2018-2029, (USD Million)
Global Pertuzumab Biosimilars production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pertuzumab Biosimilars consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Pertuzumab Biosimilars domestic production, consumption, key domestic manufacturers and share
Global Pertuzumab Biosimilars production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Pertuzumab Biosimilars production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pertuzumab Biosimilars production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Pertuzumab Biosimilars market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Zhengda Tianqing Company, Shanghai Henlius Biotech, CinnaGen, EDEN Biologics, NeuClone and Serum Institute of India, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pertuzumab Biosimilars market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pertuzumab Biosimilars Market, By Region:
1. How big is the global Pertuzumab Biosimilars market?
2. What is the demand of the global Pertuzumab Biosimilars market?
3. What is the year over year growth of the global Pertuzumab Biosimilars market?
4. What is the production and production value of the global Pertuzumab Biosimilars market?
5. Who are the key producers in the global Pertuzumab Biosimilars market?
Pertuzumab is a recombinant humanized monoclonal antibody targeting HER2
This report studies the global Pertuzumab Biosimilars production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pertuzumab Biosimilars, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pertuzumab Biosimilars that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pertuzumab Biosimilars total production and demand, 2018-2029, (K Units)
Global Pertuzumab Biosimilars total production value, 2018-2029, (USD Million)
Global Pertuzumab Biosimilars production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pertuzumab Biosimilars consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Pertuzumab Biosimilars domestic production, consumption, key domestic manufacturers and share
Global Pertuzumab Biosimilars production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Pertuzumab Biosimilars production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pertuzumab Biosimilars production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Pertuzumab Biosimilars market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qilu Pharmaceutical, Zhengda Tianqing Company, Shanghai Henlius Biotech, CinnaGen, EDEN Biologics, NeuClone and Serum Institute of India, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pertuzumab Biosimilars market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pertuzumab Biosimilars Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Human Pertuzumab
- Animal Source Pertuzumab
- Hospital
- Clinic
- Qilu Pharmaceutical
- Zhengda Tianqing Company
- Shanghai Henlius Biotech
- CinnaGen
- EDEN Biologics
- NeuClone
- Serum Institute of India
1. How big is the global Pertuzumab Biosimilars market?
2. What is the demand of the global Pertuzumab Biosimilars market?
3. What is the year over year growth of the global Pertuzumab Biosimilars market?
4. What is the production and production value of the global Pertuzumab Biosimilars market?
5. Who are the key producers in the global Pertuzumab Biosimilars market?
1 SUPPLY SUMMARY
1.1 Pertuzumab Biosimilars Introduction
1.2 World Pertuzumab Biosimilars Supply & Forecast
1.2.1 World Pertuzumab Biosimilars Production Value (2018 & 2022 & 2029)
1.2.2 World Pertuzumab Biosimilars Production (2018-2029)
1.2.3 World Pertuzumab Biosimilars Pricing Trends (2018-2029)
1.3 World Pertuzumab Biosimilars Production by Region (Based on Production Site)
1.3.1 World Pertuzumab Biosimilars Production Value by Region (2018-2029)
1.3.2 World Pertuzumab Biosimilars Production by Region (2018-2029)
1.3.3 World Pertuzumab Biosimilars Average Price by Region (2018-2029)
1.3.4 North America Pertuzumab Biosimilars Production (2018-2029)
1.3.5 Europe Pertuzumab Biosimilars Production (2018-2029)
1.3.6 China Pertuzumab Biosimilars Production (2018-2029)
1.3.7 Japan Pertuzumab Biosimilars Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pertuzumab Biosimilars Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pertuzumab Biosimilars Major Market Trends
2 DEMAND SUMMARY
2.1 World Pertuzumab Biosimilars Demand (2018-2029)
2.2 World Pertuzumab Biosimilars Consumption by Region
2.2.1 World Pertuzumab Biosimilars Consumption by Region (2018-2023)
2.2.2 World Pertuzumab Biosimilars Consumption Forecast by Region (2024-2029)
2.3 United States Pertuzumab Biosimilars Consumption (2018-2029)
2.4 China Pertuzumab Biosimilars Consumption (2018-2029)
2.5 Europe Pertuzumab Biosimilars Consumption (2018-2029)
2.6 Japan Pertuzumab Biosimilars Consumption (2018-2029)
2.7 South Korea Pertuzumab Biosimilars Consumption (2018-2029)
2.8 ASEAN Pertuzumab Biosimilars Consumption (2018-2029)
2.9 India Pertuzumab Biosimilars Consumption (2018-2029)
3 WORLD PERTUZUMAB BIOSIMILARS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pertuzumab Biosimilars Production Value by Manufacturer (2018-2023)
3.2 World Pertuzumab Biosimilars Production by Manufacturer (2018-2023)
3.3 World Pertuzumab Biosimilars Average Price by Manufacturer (2018-2023)
3.4 Pertuzumab Biosimilars Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pertuzumab Biosimilars Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pertuzumab Biosimilars in 2022
3.5.3 Global Concentration Ratios (CR8) for Pertuzumab Biosimilars in 2022
3.6 Pertuzumab Biosimilars Market: Overall Company Footprint Analysis
3.6.1 Pertuzumab Biosimilars Market: Region Footprint
3.6.2 Pertuzumab Biosimilars Market: Company Product Type Footprint
3.6.3 Pertuzumab Biosimilars Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pertuzumab Biosimilars Production Value Comparison
4.1.1 United States VS China: Pertuzumab Biosimilars Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Pertuzumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Pertuzumab Biosimilars Production Comparison
4.2.1 United States VS China: Pertuzumab Biosimilars Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pertuzumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Pertuzumab Biosimilars Consumption Comparison
4.3.1 United States VS China: Pertuzumab Biosimilars Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Pertuzumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Pertuzumab Biosimilars Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pertuzumab Biosimilars Production Value (2018-2023)
4.4.3 United States Based Manufacturers Pertuzumab Biosimilars Production (2018-2023)
4.5 China Based Pertuzumab Biosimilars Manufacturers and Market Share
4.5.1 China Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pertuzumab Biosimilars Production Value (2018-2023)
4.5.3 China Based Manufacturers Pertuzumab Biosimilars Production (2018-2023)
4.6 Rest of World Based Pertuzumab Biosimilars Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pertuzumab Biosimilars Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Pertuzumab Biosimilars Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pertuzumab Biosimilars Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Human Pertuzumab
5.2.2 Animal Source Pertuzumab
5.3 Market Segment by Type
5.3.1 World Pertuzumab Biosimilars Production by Type (2018-2029)
5.3.2 World Pertuzumab Biosimilars Production Value by Type (2018-2029)
5.3.3 World Pertuzumab Biosimilars Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pertuzumab Biosimilars Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Pertuzumab Biosimilars Production by Application (2018-2029)
6.3.2 World Pertuzumab Biosimilars Production Value by Application (2018-2029)
6.3.3 World Pertuzumab Biosimilars Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Qilu Pharmaceutical
7.1.1 Qilu Pharmaceutical Details
7.1.2 Qilu Pharmaceutical Major Business
7.1.3 Qilu Pharmaceutical Pertuzumab Biosimilars Product and Services
7.1.4 Qilu Pharmaceutical Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Qilu Pharmaceutical Recent Developments/Updates
7.1.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
7.2 Zhengda Tianqing Company
7.2.1 Zhengda Tianqing Company Details
7.2.2 Zhengda Tianqing Company Major Business
7.2.3 Zhengda Tianqing Company Pertuzumab Biosimilars Product and Services
7.2.4 Zhengda Tianqing Company Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Zhengda Tianqing Company Recent Developments/Updates
7.2.6 Zhengda Tianqing Company Competitive Strengths & Weaknesses
7.3 Shanghai Henlius Biotech
7.3.1 Shanghai Henlius Biotech Details
7.3.2 Shanghai Henlius Biotech Major Business
7.3.3 Shanghai Henlius Biotech Pertuzumab Biosimilars Product and Services
7.3.4 Shanghai Henlius Biotech Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Shanghai Henlius Biotech Recent Developments/Updates
7.3.6 Shanghai Henlius Biotech Competitive Strengths & Weaknesses
7.4 CinnaGen
7.4.1 CinnaGen Details
7.4.2 CinnaGen Major Business
7.4.3 CinnaGen Pertuzumab Biosimilars Product and Services
7.4.4 CinnaGen Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 CinnaGen Recent Developments/Updates
7.4.6 CinnaGen Competitive Strengths & Weaknesses
7.5 EDEN Biologics
7.5.1 EDEN Biologics Details
7.5.2 EDEN Biologics Major Business
7.5.3 EDEN Biologics Pertuzumab Biosimilars Product and Services
7.5.4 EDEN Biologics Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 EDEN Biologics Recent Developments/Updates
7.5.6 EDEN Biologics Competitive Strengths & Weaknesses
7.6 NeuClone
7.6.1 NeuClone Details
7.6.2 NeuClone Major Business
7.6.3 NeuClone Pertuzumab Biosimilars Product and Services
7.6.4 NeuClone Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 NeuClone Recent Developments/Updates
7.6.6 NeuClone Competitive Strengths & Weaknesses
7.7 Serum Institute of India
7.7.1 Serum Institute of India Details
7.7.2 Serum Institute of India Major Business
7.7.3 Serum Institute of India Pertuzumab Biosimilars Product and Services
7.7.4 Serum Institute of India Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Serum Institute of India Recent Developments/Updates
7.7.6 Serum Institute of India Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pertuzumab Biosimilars Industry Chain
8.2 Pertuzumab Biosimilars Upstream Analysis
8.2.1 Pertuzumab Biosimilars Core Raw Materials
8.2.2 Main Manufacturers of Pertuzumab Biosimilars Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pertuzumab Biosimilars Production Mode
8.6 Pertuzumab Biosimilars Procurement Model
8.7 Pertuzumab Biosimilars Industry Sales Model and Sales Channels
8.7.1 Pertuzumab Biosimilars Sales Model
8.7.2 Pertuzumab Biosimilars Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pertuzumab Biosimilars Introduction
1.2 World Pertuzumab Biosimilars Supply & Forecast
1.2.1 World Pertuzumab Biosimilars Production Value (2018 & 2022 & 2029)
1.2.2 World Pertuzumab Biosimilars Production (2018-2029)
1.2.3 World Pertuzumab Biosimilars Pricing Trends (2018-2029)
1.3 World Pertuzumab Biosimilars Production by Region (Based on Production Site)
1.3.1 World Pertuzumab Biosimilars Production Value by Region (2018-2029)
1.3.2 World Pertuzumab Biosimilars Production by Region (2018-2029)
1.3.3 World Pertuzumab Biosimilars Average Price by Region (2018-2029)
1.3.4 North America Pertuzumab Biosimilars Production (2018-2029)
1.3.5 Europe Pertuzumab Biosimilars Production (2018-2029)
1.3.6 China Pertuzumab Biosimilars Production (2018-2029)
1.3.7 Japan Pertuzumab Biosimilars Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pertuzumab Biosimilars Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pertuzumab Biosimilars Major Market Trends
2 DEMAND SUMMARY
2.1 World Pertuzumab Biosimilars Demand (2018-2029)
2.2 World Pertuzumab Biosimilars Consumption by Region
2.2.1 World Pertuzumab Biosimilars Consumption by Region (2018-2023)
2.2.2 World Pertuzumab Biosimilars Consumption Forecast by Region (2024-2029)
2.3 United States Pertuzumab Biosimilars Consumption (2018-2029)
2.4 China Pertuzumab Biosimilars Consumption (2018-2029)
2.5 Europe Pertuzumab Biosimilars Consumption (2018-2029)
2.6 Japan Pertuzumab Biosimilars Consumption (2018-2029)
2.7 South Korea Pertuzumab Biosimilars Consumption (2018-2029)
2.8 ASEAN Pertuzumab Biosimilars Consumption (2018-2029)
2.9 India Pertuzumab Biosimilars Consumption (2018-2029)
3 WORLD PERTUZUMAB BIOSIMILARS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pertuzumab Biosimilars Production Value by Manufacturer (2018-2023)
3.2 World Pertuzumab Biosimilars Production by Manufacturer (2018-2023)
3.3 World Pertuzumab Biosimilars Average Price by Manufacturer (2018-2023)
3.4 Pertuzumab Biosimilars Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pertuzumab Biosimilars Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pertuzumab Biosimilars in 2022
3.5.3 Global Concentration Ratios (CR8) for Pertuzumab Biosimilars in 2022
3.6 Pertuzumab Biosimilars Market: Overall Company Footprint Analysis
3.6.1 Pertuzumab Biosimilars Market: Region Footprint
3.6.2 Pertuzumab Biosimilars Market: Company Product Type Footprint
3.6.3 Pertuzumab Biosimilars Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pertuzumab Biosimilars Production Value Comparison
4.1.1 United States VS China: Pertuzumab Biosimilars Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Pertuzumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Pertuzumab Biosimilars Production Comparison
4.2.1 United States VS China: Pertuzumab Biosimilars Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pertuzumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Pertuzumab Biosimilars Consumption Comparison
4.3.1 United States VS China: Pertuzumab Biosimilars Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Pertuzumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Pertuzumab Biosimilars Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pertuzumab Biosimilars Production Value (2018-2023)
4.4.3 United States Based Manufacturers Pertuzumab Biosimilars Production (2018-2023)
4.5 China Based Pertuzumab Biosimilars Manufacturers and Market Share
4.5.1 China Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pertuzumab Biosimilars Production Value (2018-2023)
4.5.3 China Based Manufacturers Pertuzumab Biosimilars Production (2018-2023)
4.6 Rest of World Based Pertuzumab Biosimilars Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pertuzumab Biosimilars Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Pertuzumab Biosimilars Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Pertuzumab Biosimilars Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Human Pertuzumab
5.2.2 Animal Source Pertuzumab
5.3 Market Segment by Type
5.3.1 World Pertuzumab Biosimilars Production by Type (2018-2029)
5.3.2 World Pertuzumab Biosimilars Production Value by Type (2018-2029)
5.3.3 World Pertuzumab Biosimilars Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pertuzumab Biosimilars Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Pertuzumab Biosimilars Production by Application (2018-2029)
6.3.2 World Pertuzumab Biosimilars Production Value by Application (2018-2029)
6.3.3 World Pertuzumab Biosimilars Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Qilu Pharmaceutical
7.1.1 Qilu Pharmaceutical Details
7.1.2 Qilu Pharmaceutical Major Business
7.1.3 Qilu Pharmaceutical Pertuzumab Biosimilars Product and Services
7.1.4 Qilu Pharmaceutical Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Qilu Pharmaceutical Recent Developments/Updates
7.1.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
7.2 Zhengda Tianqing Company
7.2.1 Zhengda Tianqing Company Details
7.2.2 Zhengda Tianqing Company Major Business
7.2.3 Zhengda Tianqing Company Pertuzumab Biosimilars Product and Services
7.2.4 Zhengda Tianqing Company Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Zhengda Tianqing Company Recent Developments/Updates
7.2.6 Zhengda Tianqing Company Competitive Strengths & Weaknesses
7.3 Shanghai Henlius Biotech
7.3.1 Shanghai Henlius Biotech Details
7.3.2 Shanghai Henlius Biotech Major Business
7.3.3 Shanghai Henlius Biotech Pertuzumab Biosimilars Product and Services
7.3.4 Shanghai Henlius Biotech Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Shanghai Henlius Biotech Recent Developments/Updates
7.3.6 Shanghai Henlius Biotech Competitive Strengths & Weaknesses
7.4 CinnaGen
7.4.1 CinnaGen Details
7.4.2 CinnaGen Major Business
7.4.3 CinnaGen Pertuzumab Biosimilars Product and Services
7.4.4 CinnaGen Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 CinnaGen Recent Developments/Updates
7.4.6 CinnaGen Competitive Strengths & Weaknesses
7.5 EDEN Biologics
7.5.1 EDEN Biologics Details
7.5.2 EDEN Biologics Major Business
7.5.3 EDEN Biologics Pertuzumab Biosimilars Product and Services
7.5.4 EDEN Biologics Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 EDEN Biologics Recent Developments/Updates
7.5.6 EDEN Biologics Competitive Strengths & Weaknesses
7.6 NeuClone
7.6.1 NeuClone Details
7.6.2 NeuClone Major Business
7.6.3 NeuClone Pertuzumab Biosimilars Product and Services
7.6.4 NeuClone Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 NeuClone Recent Developments/Updates
7.6.6 NeuClone Competitive Strengths & Weaknesses
7.7 Serum Institute of India
7.7.1 Serum Institute of India Details
7.7.2 Serum Institute of India Major Business
7.7.3 Serum Institute of India Pertuzumab Biosimilars Product and Services
7.7.4 Serum Institute of India Pertuzumab Biosimilars Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Serum Institute of India Recent Developments/Updates
7.7.6 Serum Institute of India Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pertuzumab Biosimilars Industry Chain
8.2 Pertuzumab Biosimilars Upstream Analysis
8.2.1 Pertuzumab Biosimilars Core Raw Materials
8.2.2 Main Manufacturers of Pertuzumab Biosimilars Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pertuzumab Biosimilars Production Mode
8.6 Pertuzumab Biosimilars Procurement Model
8.7 Pertuzumab Biosimilars Industry Sales Model and Sales Channels
8.7.1 Pertuzumab Biosimilars Sales Model
8.7.2 Pertuzumab Biosimilars Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pertuzumab Biosimilars Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Pertuzumab Biosimilars Production Value by Region (2018-2023) & (USD Million)
Table 3. World Pertuzumab Biosimilars Production Value by Region (2024-2029) & (USD Million)
Table 4. World Pertuzumab Biosimilars Production Value Market Share by Region (2018-2023)
Table 5. World Pertuzumab Biosimilars Production Value Market Share by Region (2024-2029)
Table 6. World Pertuzumab Biosimilars Production by Region (2018-2023) & (K Units)
Table 7. World Pertuzumab Biosimilars Production by Region (2024-2029) & (K Units)
Table 8. World Pertuzumab Biosimilars Production Market Share by Region (2018-2023)
Table 9. World Pertuzumab Biosimilars Production Market Share by Region (2024-2029)
Table 10. World Pertuzumab Biosimilars Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Pertuzumab Biosimilars Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Pertuzumab Biosimilars Major Market Trends
Table 13. World Pertuzumab Biosimilars Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Pertuzumab Biosimilars Consumption by Region (2018-2023) & (K Units)
Table 15. World Pertuzumab Biosimilars Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Pertuzumab Biosimilars Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Pertuzumab Biosimilars Producers in 2022
Table 18. World Pertuzumab Biosimilars Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Pertuzumab Biosimilars Producers in 2022
Table 20. World Pertuzumab Biosimilars Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Pertuzumab Biosimilars Company Evaluation Quadrant
Table 22. World Pertuzumab Biosimilars Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Pertuzumab Biosimilars Production Site of Key Manufacturer
Table 24. Pertuzumab Biosimilars Market: Company Product Type Footprint
Table 25. Pertuzumab Biosimilars Market: Company Product Application Footprint
Table 26. Pertuzumab Biosimilars Competitive Factors
Table 27. Pertuzumab Biosimilars New Entrant and Capacity Expansion Plans
Table 28. Pertuzumab Biosimilars Mergers & Acquisitions Activity
Table 29. United States VS China Pertuzumab Biosimilars Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Pertuzumab Biosimilars Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Pertuzumab Biosimilars Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pertuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Pertuzumab Biosimilars Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Pertuzumab Biosimilars Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Pertuzumab Biosimilars Production Market Share (2018-2023)
Table 37. China Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pertuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Pertuzumab Biosimilars Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Pertuzumab Biosimilars Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Pertuzumab Biosimilars Production Market Share (2018-2023)
Table 42. Rest of World Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pertuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Pertuzumab Biosimilars Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Pertuzumab Biosimilars Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Pertuzumab Biosimilars Production Market Share (2018-2023)
Table 47. World Pertuzumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Pertuzumab Biosimilars Production by Type (2018-2023) & (K Units)
Table 49. World Pertuzumab Biosimilars Production by Type (2024-2029) & (K Units)
Table 50. World Pertuzumab Biosimilars Production Value by Type (2018-2023) & (USD Million)
Table 51. World Pertuzumab Biosimilars Production Value by Type (2024-2029) & (USD Million)
Table 52. World Pertuzumab Biosimilars Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Pertuzumab Biosimilars Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Pertuzumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Pertuzumab Biosimilars Production by Application (2018-2023) & (K Units)
Table 56. World Pertuzumab Biosimilars Production by Application (2024-2029) & (K Units)
Table 57. World Pertuzumab Biosimilars Production Value by Application (2018-2023) & (USD Million)
Table 58. World Pertuzumab Biosimilars Production Value by Application (2024-2029) & (USD Million)
Table 59. World Pertuzumab Biosimilars Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Pertuzumab Biosimilars Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Qilu Pharmaceutical Major Business
Table 63. Qilu Pharmaceutical Pertuzumab Biosimilars Product and Services
Table 64. Qilu Pharmaceutical Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Qilu Pharmaceutical Recent Developments/Updates
Table 66. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Zhengda Tianqing Company Basic Information, Manufacturing Base and Competitors
Table 68. Zhengda Tianqing Company Major Business
Table 69. Zhengda Tianqing Company Pertuzumab Biosimilars Product and Services
Table 70. Zhengda Tianqing Company Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Zhengda Tianqing Company Recent Developments/Updates
Table 72. Zhengda Tianqing Company Competitive Strengths & Weaknesses
Table 73. Shanghai Henlius Biotech Basic Information, Manufacturing Base and Competitors
Table 74. Shanghai Henlius Biotech Major Business
Table 75. Shanghai Henlius Biotech Pertuzumab Biosimilars Product and Services
Table 76. Shanghai Henlius Biotech Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shanghai Henlius Biotech Recent Developments/Updates
Table 78. Shanghai Henlius Biotech Competitive Strengths & Weaknesses
Table 79. CinnaGen Basic Information, Manufacturing Base and Competitors
Table 80. CinnaGen Major Business
Table 81. CinnaGen Pertuzumab Biosimilars Product and Services
Table 82. CinnaGen Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. CinnaGen Recent Developments/Updates
Table 84. CinnaGen Competitive Strengths & Weaknesses
Table 85. EDEN Biologics Basic Information, Manufacturing Base and Competitors
Table 86. EDEN Biologics Major Business
Table 87. EDEN Biologics Pertuzumab Biosimilars Product and Services
Table 88. EDEN Biologics Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. EDEN Biologics Recent Developments/Updates
Table 90. EDEN Biologics Competitive Strengths & Weaknesses
Table 91. NeuClone Basic Information, Manufacturing Base and Competitors
Table 92. NeuClone Major Business
Table 93. NeuClone Pertuzumab Biosimilars Product and Services
Table 94. NeuClone Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. NeuClone Recent Developments/Updates
Table 96. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 97. Serum Institute of India Major Business
Table 98. Serum Institute of India Pertuzumab Biosimilars Product and Services
Table 99. Serum Institute of India Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 100. Global Key Players of Pertuzumab Biosimilars Upstream (Raw Materials)
Table 101. Pertuzumab Biosimilars Typical Customers
Table 102. Pertuzumab Biosimilars Typical Distributors
LIST OF FIGURE
Figure 1. Pertuzumab Biosimilars Picture
Figure 2. World Pertuzumab Biosimilars Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pertuzumab Biosimilars Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Pertuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 5. World Pertuzumab Biosimilars Average Price (2018-2029) & (US$/Unit)
Figure 6. World Pertuzumab Biosimilars Production Value Market Share by Region (2018-2029)
Figure 7. World Pertuzumab Biosimilars Production Market Share by Region (2018-2029)
Figure 8. North America Pertuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 9. Europe Pertuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 10. China Pertuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 11. Japan Pertuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 12. Pertuzumab Biosimilars Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 15. World Pertuzumab Biosimilars Consumption Market Share by Region (2018-2029)
Figure 16. United States Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 17. China Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 18. Europe Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 19. Japan Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 20. South Korea Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 22. India Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Pertuzumab Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pertuzumab Biosimilars Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pertuzumab Biosimilars Markets in 2022
Figure 26. United States VS China: Pertuzumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Pertuzumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pertuzumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Pertuzumab Biosimilars Production Market Share 2022
Figure 30. China Based Manufacturers Pertuzumab Biosimilars Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Pertuzumab Biosimilars Production Market Share 2022
Figure 32. World Pertuzumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Pertuzumab Biosimilars Production Value Market Share by Type in 2022
Figure 34. Human Pertuzumab
Figure 35. Animal Source Pertuzumab
Figure 36. World Pertuzumab Biosimilars Production Market Share by Type (2018-2029)
Figure 37. World Pertuzumab Biosimilars Production Value Market Share by Type (2018-2029)
Figure 38. World Pertuzumab Biosimilars Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Pertuzumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Pertuzumab Biosimilars Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Pertuzumab Biosimilars Production Market Share by Application (2018-2029)
Figure 44. World Pertuzumab Biosimilars Production Value Market Share by Application (2018-2029)
Figure 45. World Pertuzumab Biosimilars Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Pertuzumab Biosimilars Industry Chain
Figure 47. Pertuzumab Biosimilars Procurement Model
Figure 48. Pertuzumab Biosimilars Sales Model
Figure 49. Pertuzumab Biosimilars Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World Pertuzumab Biosimilars Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Pertuzumab Biosimilars Production Value by Region (2018-2023) & (USD Million)
Table 3. World Pertuzumab Biosimilars Production Value by Region (2024-2029) & (USD Million)
Table 4. World Pertuzumab Biosimilars Production Value Market Share by Region (2018-2023)
Table 5. World Pertuzumab Biosimilars Production Value Market Share by Region (2024-2029)
Table 6. World Pertuzumab Biosimilars Production by Region (2018-2023) & (K Units)
Table 7. World Pertuzumab Biosimilars Production by Region (2024-2029) & (K Units)
Table 8. World Pertuzumab Biosimilars Production Market Share by Region (2018-2023)
Table 9. World Pertuzumab Biosimilars Production Market Share by Region (2024-2029)
Table 10. World Pertuzumab Biosimilars Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Pertuzumab Biosimilars Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Pertuzumab Biosimilars Major Market Trends
Table 13. World Pertuzumab Biosimilars Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Pertuzumab Biosimilars Consumption by Region (2018-2023) & (K Units)
Table 15. World Pertuzumab Biosimilars Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Pertuzumab Biosimilars Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Pertuzumab Biosimilars Producers in 2022
Table 18. World Pertuzumab Biosimilars Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Pertuzumab Biosimilars Producers in 2022
Table 20. World Pertuzumab Biosimilars Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Pertuzumab Biosimilars Company Evaluation Quadrant
Table 22. World Pertuzumab Biosimilars Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Pertuzumab Biosimilars Production Site of Key Manufacturer
Table 24. Pertuzumab Biosimilars Market: Company Product Type Footprint
Table 25. Pertuzumab Biosimilars Market: Company Product Application Footprint
Table 26. Pertuzumab Biosimilars Competitive Factors
Table 27. Pertuzumab Biosimilars New Entrant and Capacity Expansion Plans
Table 28. Pertuzumab Biosimilars Mergers & Acquisitions Activity
Table 29. United States VS China Pertuzumab Biosimilars Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Pertuzumab Biosimilars Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Pertuzumab Biosimilars Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pertuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Pertuzumab Biosimilars Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Pertuzumab Biosimilars Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Pertuzumab Biosimilars Production Market Share (2018-2023)
Table 37. China Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pertuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Pertuzumab Biosimilars Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Pertuzumab Biosimilars Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Pertuzumab Biosimilars Production Market Share (2018-2023)
Table 42. Rest of World Based Pertuzumab Biosimilars Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pertuzumab Biosimilars Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Pertuzumab Biosimilars Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Pertuzumab Biosimilars Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Pertuzumab Biosimilars Production Market Share (2018-2023)
Table 47. World Pertuzumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Pertuzumab Biosimilars Production by Type (2018-2023) & (K Units)
Table 49. World Pertuzumab Biosimilars Production by Type (2024-2029) & (K Units)
Table 50. World Pertuzumab Biosimilars Production Value by Type (2018-2023) & (USD Million)
Table 51. World Pertuzumab Biosimilars Production Value by Type (2024-2029) & (USD Million)
Table 52. World Pertuzumab Biosimilars Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Pertuzumab Biosimilars Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Pertuzumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Pertuzumab Biosimilars Production by Application (2018-2023) & (K Units)
Table 56. World Pertuzumab Biosimilars Production by Application (2024-2029) & (K Units)
Table 57. World Pertuzumab Biosimilars Production Value by Application (2018-2023) & (USD Million)
Table 58. World Pertuzumab Biosimilars Production Value by Application (2024-2029) & (USD Million)
Table 59. World Pertuzumab Biosimilars Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Pertuzumab Biosimilars Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 62. Qilu Pharmaceutical Major Business
Table 63. Qilu Pharmaceutical Pertuzumab Biosimilars Product and Services
Table 64. Qilu Pharmaceutical Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Qilu Pharmaceutical Recent Developments/Updates
Table 66. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 67. Zhengda Tianqing Company Basic Information, Manufacturing Base and Competitors
Table 68. Zhengda Tianqing Company Major Business
Table 69. Zhengda Tianqing Company Pertuzumab Biosimilars Product and Services
Table 70. Zhengda Tianqing Company Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Zhengda Tianqing Company Recent Developments/Updates
Table 72. Zhengda Tianqing Company Competitive Strengths & Weaknesses
Table 73. Shanghai Henlius Biotech Basic Information, Manufacturing Base and Competitors
Table 74. Shanghai Henlius Biotech Major Business
Table 75. Shanghai Henlius Biotech Pertuzumab Biosimilars Product and Services
Table 76. Shanghai Henlius Biotech Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shanghai Henlius Biotech Recent Developments/Updates
Table 78. Shanghai Henlius Biotech Competitive Strengths & Weaknesses
Table 79. CinnaGen Basic Information, Manufacturing Base and Competitors
Table 80. CinnaGen Major Business
Table 81. CinnaGen Pertuzumab Biosimilars Product and Services
Table 82. CinnaGen Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. CinnaGen Recent Developments/Updates
Table 84. CinnaGen Competitive Strengths & Weaknesses
Table 85. EDEN Biologics Basic Information, Manufacturing Base and Competitors
Table 86. EDEN Biologics Major Business
Table 87. EDEN Biologics Pertuzumab Biosimilars Product and Services
Table 88. EDEN Biologics Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. EDEN Biologics Recent Developments/Updates
Table 90. EDEN Biologics Competitive Strengths & Weaknesses
Table 91. NeuClone Basic Information, Manufacturing Base and Competitors
Table 92. NeuClone Major Business
Table 93. NeuClone Pertuzumab Biosimilars Product and Services
Table 94. NeuClone Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. NeuClone Recent Developments/Updates
Table 96. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 97. Serum Institute of India Major Business
Table 98. Serum Institute of India Pertuzumab Biosimilars Product and Services
Table 99. Serum Institute of India Pertuzumab Biosimilars Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 100. Global Key Players of Pertuzumab Biosimilars Upstream (Raw Materials)
Table 101. Pertuzumab Biosimilars Typical Customers
Table 102. Pertuzumab Biosimilars Typical Distributors
LIST OF FIGURE
Figure 1. Pertuzumab Biosimilars Picture
Figure 2. World Pertuzumab Biosimilars Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pertuzumab Biosimilars Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Pertuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 5. World Pertuzumab Biosimilars Average Price (2018-2029) & (US$/Unit)
Figure 6. World Pertuzumab Biosimilars Production Value Market Share by Region (2018-2029)
Figure 7. World Pertuzumab Biosimilars Production Market Share by Region (2018-2029)
Figure 8. North America Pertuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 9. Europe Pertuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 10. China Pertuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 11. Japan Pertuzumab Biosimilars Production (2018-2029) & (K Units)
Figure 12. Pertuzumab Biosimilars Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 15. World Pertuzumab Biosimilars Consumption Market Share by Region (2018-2029)
Figure 16. United States Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 17. China Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 18. Europe Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 19. Japan Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 20. South Korea Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 22. India Pertuzumab Biosimilars Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Pertuzumab Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pertuzumab Biosimilars Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pertuzumab Biosimilars Markets in 2022
Figure 26. United States VS China: Pertuzumab Biosimilars Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Pertuzumab Biosimilars Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pertuzumab Biosimilars Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Pertuzumab Biosimilars Production Market Share 2022
Figure 30. China Based Manufacturers Pertuzumab Biosimilars Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Pertuzumab Biosimilars Production Market Share 2022
Figure 32. World Pertuzumab Biosimilars Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Pertuzumab Biosimilars Production Value Market Share by Type in 2022
Figure 34. Human Pertuzumab
Figure 35. Animal Source Pertuzumab
Figure 36. World Pertuzumab Biosimilars Production Market Share by Type (2018-2029)
Figure 37. World Pertuzumab Biosimilars Production Value Market Share by Type (2018-2029)
Figure 38. World Pertuzumab Biosimilars Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Pertuzumab Biosimilars Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Pertuzumab Biosimilars Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Pertuzumab Biosimilars Production Market Share by Application (2018-2029)
Figure 44. World Pertuzumab Biosimilars Production Value Market Share by Application (2018-2029)
Figure 45. World Pertuzumab Biosimilars Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Pertuzumab Biosimilars Industry Chain
Figure 47. Pertuzumab Biosimilars Procurement Model
Figure 48. Pertuzumab Biosimilars Sales Model
Figure 49. Pertuzumab Biosimilars Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
